PETR4:BMFBOVESPAPetroleo Brasileiro SA Pfd Analysis
Data as of 2026-03-10 - not real-time
R$42.37
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Petrobras (PETR4) is trading at BRL 42.37, well below its DCF‑derived fair value of BRL 87.27, implying a sizeable valuation gap. Technical momentum is bullish, with the 20‑day SMA (39.37) sitting above the 50‑day SMA (35.69) and the 200‑day SMA (32.41), while the MACD line remains above its signal line and the RSI is elevated at 73, indicating strong upward pressure but also a near‑overbought condition. Fundamentally, the stock appears cheap – a trailing P/E of 5.2 versus an industry average of 20.5, a P/B of 1.31, and a dividend yield of 10.75% supported by a modest payout ratio of 38%. The company generates robust cash flow (operating cash flow BRL 200.3 bn, free cash flow BRL 85.0 bn) and maintains a solid liquidity cushion despite a high debt‑to‑equity ratio of 92, aided by a low beta (~0.37) and a 30‑day volatility of 26.5%. Recent material news underscores Petrobras’ continued focus on dividend distribution and diversification into low‑carbon energy, reinforcing the sustainability of its high yield. With support around BRL 36.53 and resistance near BRL 44.27, the stock is positioned for further upside, especially given the “Extreme Greed” sentiment reflected in the fear‑greed index.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD and SMA alignment
- Elevated RSI suggesting near‑overbought but still upward bias
- Strong dividend yield supporting investor interest
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Large valuation gap to DCF fair value
- Low P/E relative to industry peers
- Robust cash flow and sustainable dividend payout
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable high dividend yield with low payout ratio
- Strategic diversification into low‑carbon and gas businesses
- Undervalued pricing relative to fundamentals and long‑term cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth5.00%
Profit Margin22.13%
P/E Ratio5.2
ROE28.18%
ROA8.61%
Debt/Equity91.96
P/B Ratio1.3
Op. Cash FlowR$200.3B
Free Cash FlowR$85.0B
Industry P/E20.5
Technical Analysis
TrendBullish
RSI73.0
SupportR$36.53
ResistanceR$44.27
MA 20R$39.37
MA 50R$35.69
MA 200R$32.41
MACDBullish
VolumeIncreasing
Fear & Greed Index77.18
Valuation
Fair ValueR$87.27
Target PriceR$42.58
Upside/Downside0.51%
GradeUndervalued
TypeValue
Dividend Yield10.75%
Risk Assessment
Beta0.37
Volatility26.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.